(Q39444998)

12 September 2017

1 reference

title

Rational treatment of addiction (English)

1 reference

12 September 2017

L Terenius

1

1 reference

12 September 2017

publication date

1 August 1998

1 reference

Current Opinion in Chemical Biology

12 September 2017

published in

1 reference

12 September 2017

volume

2

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

541-547

1 reference

Myths about the treatment of addiction.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

The Sensitizing Effect of Tetraethylthiuramdisulphide (Antabuse) to Ethylalcohol

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Disulfiram treatment of alcoholism. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Kudzu root: an ancient Chinese source of modern antidipsotropic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Endorphins and experimental addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Cannabinoid receptor localization in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Ultrashort noninvasive opiate detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Research strategies to assess pharmacotherapies for alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Failure of ritanserin to block cocaine cue reactivity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Efficacy of buspirone in alcohol dependence: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Effect of naltrexone on alcohol "high" in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Buprenorphine suppresses heroin use by heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Buprenorphine suppresses cocaine self-administration by rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Acamprosate appears to decrease alcohol intake in weaned alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Molecular and cellular basis of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Quantitative trait loci involved in genetic predisposition to acute alcohol withdrawal in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Acute effects of cocaine on human brain activity and emotion.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Prevalence, detection, and treatment of alcoholism in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Opioid modulation of alcohol intake in monkeys by low doses of naltrexone and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Naltrexone in the treatment of alcoholism: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

GABAA, NMDA and AMPA receptors: a developmentally regulated 'ménage à trois'.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980132-4

7 January 2021

10.1016/S1367-5931(98)80132-4

Identifiers

DOI

1 reference

12 September 2017

1 reference